Drugs / Velbe
last change Oct 2021 re-read 3 minutes ago

Velbe

Developed for
extragonadal nonseminomatous germ cell tumor
Investigated by
Centre Leon Berard

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02104986 May 2014 → Oct 2021 extragonadal nonseminomatous germ cell tumor Centre Leon Berard Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Velbe ClinicalTrials.gov intervention name — accepted as the source's own label NCT02104986 ↗